RePORT OVTME TRusfEES AND
UIIAUDrrED FIIIANCIAL sfATEMEIITS FIX THE YEAR ENDED 31 DECEMBER 2024
29 Glbdredge Road
BN214RU

coIKrEirfs OF THE FINANCIAL sfATEMEpirs
FOR THE YEAR ENDED 31 DECEMBER 2024
TAR 1-14
Soclety InfonNth
Indep￿d•￿t Ex•mln•V• Rwt
st¥tement of fln•nd•l Actlvld
B•l•rtc• She•t
5 to 11
12 to 13

Trustees, Annual Report for the period
Period start date
jDay
101
Period end date
Month
From
01
2024
31
2024
Section A
Reference and administration details
Charity name
International Society of Hypertension
Other names charity 15 known by
ISH
Registered charitable incorporated
organisBtion ICIOI number 1204969.
Formerly ISH was an unincorporated charity
with registered number1122135.
Registered charity number lif anyl
Charity's prlncipal address
29 Gildredge Road
Eastbourne
East Sussex
Postcode
8N214RU
Names of the charitytrustees who manage the charity
Narne of
person lor
body) entitled
to appoint
trustee lif any)
Dates acted If not for
whole year
Trustee name
Office lif any)
George Stergiou (Greecel
Secretary
President
01.01.24- 21.09.24
21.09.24- 31.12.24
21.09.24- 31.12.24
Dagnovar Aristizabal
Icolombial
Hind Mamoun Beheiry
Ahmed (Sudanl
Cl8udio Borghi Iltalyl
Fadi Charchar (Austral￿8>
Myeong-chan Cho (South
Koreal
Débora Colombari (Brazill
Hiroshi Itoh Ilapanl
Erika lones (South Africa)
Nadia Khan (Canada)
Kazuomi Kario Ilapan
21.09.24- 31.12.24
01.01.24- 21.09.24
01.01.24- 21.09.24
01.01.24-31.12.24
Treasurer
21.09.24- 31.12.24
01.01.24-31.12.24
21.09.24- 31.12.24
01.01.24- 21.09.24
01.01.24- 21.09.24
21.09.24- 31.12.24
01.01.24-31.12.24
21.09.24-31.12.24
01.01.24- 21.09.24
Vice President
Offi¢er at Large
Officer at Large
10
Secretary
12
Tazeen lafar Isingaporel
Yan Li Ichinal
Dorairaj Prabhakaran
Ilndial
Cesar Romero IUSAI
14
01.01.24- 21.09.24
21.09.24- 31.12.24
01.01.24-31.12.24
15
Treasurer
Ulrike Steckelings
(Denmarkl
Maciej Tomaszewski IUKI
Bryan Willi8ms IUKI
Immediate Past President
President
Immediate P8St President
01.01.24- 21.09.24
01.01.24-21.09.24
21.09.24- 31.12.24
TAR

Names and addro$se$ otadvlsers (Optlonal Informatlon)
Type of advlsor
Namo
Addre88
Accountant
Advants Chartered
29 Gildredge Road. Easts)oume. East Sussex, BN214RU, UK
Accountsnts
N8m• of chlef executhie or names of senlor staff MeM￿r$I0 tlonal Infomiatlon)
NIA
Sectior) B
Structure, zovernciiice rid In[?ni< oement
Descrfption of the ¢harltystrusts
Type of governlng document
leg. trusl Lleed, constitution)
The current ISH Constitution was Ini￿allY accepted bysociety memb8rs on 26
September2022. However, itwas leg811y 8CCePted on 29 September 2023, when
ISH vffjs officially registered as a Charitsble Incorporated Organisation ICIO) in
England and Wales (registration number 12049691.
Howthe charity is constituted
leg. trust. association, company)
The ISH is 8 registèred Ch8rit8ble IncorpOr￿ed Org8nisation ICIOI in Eng￿nd
and Wales Ireostration number 12049691 registered on 29 September 2023. The
Societywas previously an Unincorporated Charity IUCI registered under number
1122135.
80th the ISH entitie5- the UC and the CIO- operated concurrentty for a period.
while new bank a¢¢ounts ¥ft￿ estsbil$hed, and systems were fully
Implemented.
Thetransferofallfunds and netassetsfromthe ISH Uctothe ISH ClOv￿S
formalty completed on 23" December 2024.
The Executive Committee of ISH concluded thattransitioningfrom an UC to
CIO offered signfficant advantsges to the Society.
The Most important b8nefits of the CIO structure to the ISH ar8:
Separate Leg81 Pèrsonality. The CIO has its own legal Identity, allowing it
to enter into contracts. own property. and conduct all business in the
charltys name, ratherth8n in the names ofthe indiwdual Trustees.
Twstee Protection {Llmtted Liability): Members and Trustees are
generally protected from personal liabiiityfor 8ny debts or obligations
incurred bythe charity. This is a critical improvement, as Trustees ofthe
prv4ious UC were each and severally liable forthe debts of ISH.
The Trustees of the old charty andthe CIO at the time of the transfer were the
$8rn8 persons. Accordingly. for most pr8Ctical purposes th8 charity is
continuing as before.
Trustee selection method$
leg- <ippointe(J by. elected by)
A callfor nominations is made to membership. Votes are ¢8St by members ata
(Bienniall General Meeting or by an electronic b811ot. Those who are 8lect8d to
membership of the ISH Councll forthe succeedingfour years become Trustees
and arnfomalty 8ppoint8d 8t tho General Meetlng.
Addttlonaigovernance Issues IOptlonallnfom￿onj
You may ehoose to include
additional information. ¥¥her8
relevant. about:
Poli¢i85 and procedures adopted
for the induction and tralnlng of
In 2024. the ISH had an actNe membership of 1,905 experts from 110 countries
Vltth 5 Corporate Member industy partners. ISH is a network committed to
research and education for healthcare and allied professionals in the field of
hypertension (high blood pressure) and on preventlng its consequences. and for
TAR

trustees.
The charity's organis8tional
structure and any wider network
with which the charity works.
Relationship with any related
parties.
Trustees, consideration of major
risks and the system and
procedures to manage them.
public information on hypertension.
The daily management of the ISH is undertaken by an Executive Committee (the
Executive) on behalf of the Council, comprising of Officers of the Society..
(President. Vice President, Secretary, Treasurer. Officer 8t Large and Immediate
Past President). as well as an additional number of other elected Council
Members as determined by the President.
Committees and groupings have been established to assist with the
management of the day-to-day activities of the Society. E8eh Committee is
chaired by 8 member of the Council or by a Society member la list of all the
committees can be found on the Society website). Altogether. the members of
ISH Executive, the Council and all the members of ISH Committees constitute
the ISH leadership.
ISH administrative support for mernbership, communications, finance and other
identified areas is maintained by external service provi(Jers Inotably Canica for
membership and website management). The Society has one ISH employee with
key responsibilities to support the Executive. Council, and the ISH leadership.
The aim is for this dedicated full-time support to help the Society and volunteers
and maintain continuity with activities.
As the Society does not undertake fundraisingfrom the general public, the major
risks to the continuation of the Society's programrne of educational activities
are from 8 decrease in income from its industry partners, reduction in revenue
from the Journal of Hypertension annual royalty fee and from its Biennial
Scientific Meetings. Traditional and social media marketing and publicity is used
to attract attendance to the ISH meetings. Amounts Spent to achieve the Society
Objecis of education are limited by the income received (see under'Reserves
Policy, in section E, below).
Section C
Objectives and activities
Summaryofthe
objects of the
charity set out in
its governing
document
To protect and promote the health of the public in particular by encouraging the advancement
of scientific research and knowledge and of its application in all aspects of hypertension and
associated cardiovascular diseases and to disseminate the useful results ol such research.
Education:
ISH prim8rily works with aff iliated societies in the region5 to forge stronger links with national
and regional societies of hypertension and related bodies, to create wider awareness of the
Society and importantly, to otfer support and help educate those in countries and regions
most in need.
Summary ofthe
main activities
undertaken forthe
public benef it in
relation to these
objeGts linclude
within this section
the statutory
declaratlon that
trustees have had
regard to the
guidance issued by
the Charity
Commlssion on
public benefit)
ISH Regional Advisory Groups (RAGS) ensure that the Society is listening and responding io all
members of its international constituency with a local flavour. Since October 2020, the map of
ISH RAGS has been aligned with six World Health Organization (WHO) regions., there are RAGS
in ISH as follows-
1. Alrica
2. Americas
3. Asia Pacific IAPACI
4. Europe
Middle East and North Africa IMENAI
6. South and Central Asia ISACAI
These groups are intended to provide comprehensive Society representation globally. to distil
regional issues, encourage and enhance education and biomedical research in the fields of
hypertension and associated cardiovascular diseases, support the emergence ol new regional
TAR

and national societie$, vffjrk with existing Societies to undertakejolnt projects in the
propagatlon of hypertension prevenlion and facilltate closerworkSng rela￿onshIpS and
collaboration betsveen overlapplng regional gmups.
BlennlalsCle￿fflc Meotlngg:
The ISH Biennial Scientrfic Meetings are 8 plattorm for presentin8 completed and original
scientific investigations and where delegates from all overthe wortd can meet and discuss
pUb￿C health. clinical and population aspects ot hypertension r8S8arch. S88 section D tor
further information on plans that are underwaytorthe 2026 and 2028 events.
Now Invostlgator and Montorshlp andTrnlnlng cornn￿tt¢•$.
It has been the mission of the ISH to encourage and support younger r&se8rch8rs, as the next
generatlon of leaders in the global management of blood pressure. Through the continued
development ofthe New Investigatorand Mentorship and Training Commtttees and the
related New Investigator Network and mentorship webp8g8s (bt1p￿￿-
and presence on Social media platforms
(Facebook, X. Instsgram.YouTube and Linkedlnl. aswè118S thelaunch ofthe newCap8city
Building Network at the end of 2023. the Society is extending ￿ reach to the new generation of
researchers and doctors and future leaders in thefield.
Womon in Hyporten$lon Rowr¢h Notwork"
The ISH Women in Hypertension Rese8rch Network was established in 2016 to encourage.
support and Inspire women in science and medicine in the field of hypertension and related
cardiov8scuL8r diseases. Itaims to allow new avenues for communication, Collaboratlon and
education. The key aims ate:
To promote Tlvomen scientists and clinicians so thatthey can fulfil their career
aspirations in th8field of hypertension 8nd rg18ttsd c8rdiovascuiar diseases.
Promde a pLatfom for ne￿rkIn￿and mentoringto enable women hypertension
researchers to maximlse career opportunfties. In partlcuiar. to reach outto those who
do not have fonnal mentoring support.
Recognise and promote the successès ol women in the hypertension communty.
Involve all ISH members in promoiing equalopportunities for women in science and
medicine based on merit.
Affiliated Society Ènd Partnor Couaborationg:
Increasingty effective links have been torged amongst national and regional societies of
hypertension and high blood pressure research councils around the world vi8 our six Regional
Advisory Groups. providing a piatformfor res88rch and intellectU81 exchange of ideas
pertinent to scientific, economic and ethical aspects of cardiovascuLar preventlon and caffj.
Th8 ISH RAGS additionally help to provide compr8hen8Ne Society representation globally. to
resolve regional issues and encourage and enhance educatlon and biomedlcal research in the
fields of hypertension and associated cardiovascular diseases.
PubU¢ Awar•ness:
World Hypertenslon Day(17May):
Raised blood pressure is the biggest single contributing risk factorfor global death. Lots more
needs to be done ty govemments. public health agencies and healthcare systems to counter
the devaststlng and perpetual menace of hypertension-the silent killer. As a result of the
r8pidlygrowing burden of disease associatèd with the global increase in hypertension the
Society supports and encourages involvemenl in the annualworid Hypertension Day on 17
May bysociety members and affiliated regional and national societi8s (established by our
partner organisation World Hypertension League).
The theme otWHD in 2024 wa8'Measureyour blood prossure accuratoly, control It. Ilve
longer, focusing on combatting low awareness rates worldwide. especially in iow-and middle-
income areas. and accurate blood pressure measurement methods. As a part of commitm8nt
to awareness of hi0) blood pressure. on 17 May 2024 the Society released a shortvideo to
TAR

amplifythe mess8g8that 10 miuion d88ths 8veryy8ar acro88 the wortd could have been
avolded sf high blood pressure had been detected and treated. Furthermore. th8 Soclety
curatsd and shared a resource page highiightingtsntastlc global activities tsking place by
m8ny of ourAffiliated Societies and members to markWHD and to act as a prompt for peopl8
to get Ihelr blood pressure checked rf not checked befoo.
Plans We￿ oddltlonaltyadvanced In 2024 towrlte an ISH Patient-locvsed guidellne designed
to empower and raikio patients. The Soclety has recognlsed thattherè is a need to create a
iayfriendly document to better Communicato wlth patlents. explain what18 h8ppenlngto them
and help them galn more control and understsnding regardlngthelr own blood pressure 8nd to
lacilltate a transfer of power. The docUmentV￿lI outllne the optlmal standards and the
minimum 8tsnd8rds th8t must be achieved. The docum8ntV•ryll be tallored to dlflerent levels of
understgnding and made avaliabie In different iangu8g88 to faclltste adoptlon of the guldellne
In the reglons.
World Adhoron¢¢ Day
Wlth p8rtner organlsatlons Ilncludlngthe Wortd H88rt F8dgratlonl. the ISH was Involved In
2024 In the establl8hment of a new Inltl8tfve- World Adherence Day. Thls Is an Inltl8tlv8 almed
al ralslng 8w8ren988 about the Importanc8 of stlcklngto pre8¢rlbed he81thcare plans. The flrst
World Adherence Dayvlll be obseMd on 27 March 2025. The day emphaslses tho
signlflcance ol adherence to treatments. 88pec1811y for chronlc conditions, to Improve health
outcomes and reduce ¢ompllcatlon8.
The c8rnpaign oncour8g88 SndMdu818 to fouowthelr h•8lthcare provld8rs' recommendatlons,
whether11 Involves mgdlc8tlon. Ufestyie ch8ngès. or malntalnlng a healthy routSne. The thema
lor the day In 2025 wlll be"Don't Mlss a Moment.. highiightlng the Importance of Staylng on
tr8ck wlth healthcare plans to protect meanlngfvi moments In Ufe.
World Adh8r8nc8 Dayw88 publlc188d at the ISH2024 meetlng In the ISH Gattagena
May M•••urom•ffl Month:
Bulldlng on the success of the exlsttngwHD. thg ISH d8¥ignated thg entlre month of May a8
M8yMea8urement Month IMMMI In2017.Thealmwa8 to hl8thiightthe Importance ol
meosurlngyour blood pre88ure IBPI and lo r81s8 8w8rene38 01 the dangers poged by elevated
8P and hyperten8lon. The target Is to Incre8se the number8 of p8rt1clpants aged 18+ who are
reguL8rtygettlng thelr BP checked and to gbve people the too18 to understand how th18
Infomiatlon can contrlbutg to a person's knO￿ed89 about thelr IndMdu81 h88lth. MMM 8180
provldes dlet and Ilfesfyie 8¢fvice to those wlth 8P In the hypertenslvo r8nge 8nd to facllltste
Improved follow up foi suffgrgr8.
The ISH188d8r8hlp introduced a nèw model of gDV8rn8nce for the MMM Inltlatlve. whlch
became effectlve from 10t January 2022. Thls Is because the expanslon of MMM was
Incfeaslngiy consumlng leadershlp tlme and resources from the ISH. dlstractlng from the
opportunltyto launch new Inltlattves. In thls newarrangement, MMM has become an
Independent charity In England and Walès. However. th8 campaign contlnues to remaln
strongly afflllated wlth the ISH as the foundlng p8rtner8nd successful MMM activltles took
place once 88ain in m8ny parts of thoworid in 2024.
Publlo Bon
The Trustees have read theguidance issued bythe Ch8rbty Commission rel8tlngto publlc
benefit and can ¢ontinn that the above 8¢tivities of the ISH benefit the public in general. Thls Is
8chieved by Improving the depth and spread of knowledge In the field of hypertension and
cardiovascular dlsease. fosteringthe transL8tlon of novel clinlcal research and b8sic science
into best cllnl¢al practice and increasing public awareness ol raised blood pressure.
Upskllling practltloners improves healthcare forall those v￿th hypertension and oth8r related
diseases. The charlty h8$ a track record of organlslng hlghquallty educatlonal courses.
seminars, and meetings all overthe world. as V￿lI as providing expert faculty memb8rs to
disseminate ihe Latest hypertenslon management guidelines. All these activities result in
increased th0￿edge ty clinicians treating h
ertension. There are no restrictions to thi8
TAR

overall beneflt In healthcare, as 8pe¢lfled in the Charity Commission guldgnce le.g., in temis
of access, geography, membershlp, abilltyto pay etcl.
Scction D
Achievements and performance
Summaryoftho
maln
a¢hlavement$ of
the¢harltydurlng
tho year
Thesocletyhas a d8dlcat8d M8mber5hlpCommitteeto:
11} actlvely recruit new members
121 attract more geographically comp￿hen85ve membership and expand ISH'S global
footprint of members
131 retain members and encourage 8CtNe participation
141 incre888 th8 number of paying members
Members Sn 2024 Included tralnees, lunior and established scientists. clinicians. health
care providers 8nd allied health care workers from across the gbbe, all wlth a common
interest in hypertension research and patlent care.
Atthe end of 2024. the Society had 1.905 members constiluting 1.202 Members (including
96 ISH Fellows. 14 DSstinguished, 59 Emerltus and 3 Honorary Fellows). 235 Trainees and
468 Assoclate Members. In addition, there were 5 Corporate Members {organisation-
industry partners).
The ten countries with the high8St number of membèrs included Japan, United States,
Australia. China. Canada. India. UK. Nigeria. South Kor88 and South Africa.
The ISH contlnued to workvAth a membershlp management org8nisatlon based in
Argentina in 2024to improve the interface with ISH members. Worklng In Latin Amerlca is
allowing the Society to Open our door8 to the large Spanish speaking hypertension
communitythat had previously been untspped bythe ISH.
The ISH leadership used this period of change as a great opportunity to set in motion a
large membershlp restructure, designed to make membership more accessible for anyone
with an interest in hypertension globally and to improve the overall membership
experience. This restructure was Completed in 2024.
Aehlevementg In 2024:
Membershlp restructure plans were concluded and mede posslblewlth the
assistance of an enthusiastic and dfiven Membership Commlttee chair and members.
Changes agreed wlth the restructure included:
A nèw and $impiifi8d set of membership cat8gori88 to Member. Traine8 8nd
Asso¢late Member.
Reduced fees and free memberships for m8mb8rs from parts ofthè world where
fees can be a barrierto membership.
Extensive promotion ofthe ￿ free membershlp catègories Ws80Cl8t8 Member
end Traineel exlenslvely atvarlous events globally and on soclal medi8.
A refreshed membership portal offering members access to training. resources.
and other member beneflts. Previously all information had been accessible to
members onlyvia th6 open ISH v￿b pages.
As a result of our membership restructure and promoilon, w8 galned approximstely
800 newmemb8rs ofthèsocietyin 2024.
TAR

Section D
Achievements and performance
A much-reLluced cost subscription to the ISH'S official Journal- the Journal ol
Hypertension-continued to be offeredto members via the membership portal.
ISH 2024 Scientific Meeting
The 30th Scientific Meeting of the Intemational Society of Hypertension took p12ce from 19-22
Septernber 2024. in Cartagena de Indias, Colombia, with pre-event sessions held on 18
September. This event. held in conjunction with the Colombian Society of Cérdiology and
Cardiovascular Surgery was supported by several key societies in the Tegion.
The meeting hadthetheme'lmprovingthe Controlof Hypertensionworldwide. and was
supported by approximately 1.500 participants from over 60 countries. including 160 speakers
from over 35 countries. 472 abstracts weie submitted for the presentation of research and
285 abstracts presented in oral or poster presentation sessions. We also garnered support
from 26 Sponsors forthe meeting.
Multiple topics were covered at the meeting including eardiovas¢uLar risk tactofs,
epidemiology of hypertension and metabolic disorders. blood pressure rneasurement. stroke.
obesity and metabolic syndrome, hypertension rnediated organ darnage. res1Stant
hypertension and diabetes. hypertension in pregnancy amongst others. Keynote sessions at
the event discussed Al in healthcare. Genetics and genomics of sex determination and the
Genetics of bloo(J pressure.
Se55ions were devoted to furthering the ISH'S educational agenda. The programme included a
variety ofjoint sessions with ISH partners such 8S the Latin American Society of Hypertension
ILASHI. European Society of Hypertension IESHI, World Hypertension League IWHLI, Korean
Hypertension Society IKSHI. American College ol Cardiology IACCI. There was a focus on
the various regions of the world with sessions facilitated by three of the six ISH Regional
Advisory Groups and dedicated slots in the programme lor women in hypertension research,
mentorship. communication and new investigators.
The ISH Capacity Building Network carried out successful activities at the evenl including two
Speed Mentoring Lunchtime Sessions and a full day symposium on 18 September designed to
help attendees communicate research eftectively, build their research networks and write a
successful grant application. This event was attended by over 50 trainees. To add to this. the
Society announced the 2024 ISH Collaboration Exchange Scholarship valued at USD 5,000.
The aim of the ISH Collaboration Exchange Scholarship is to support the development of
collaborative relationships andlor activities with someone they rnet at the 2024 ISH meeting.
We have nowawarded two successful applicants with USDS,000 each.
A record number of nominations were received in 2024 for the ISH Biennial awards, and
winners were presented by the Society at the Cartagena 2024 meeting to honour members for
their achievements. New awards developed forthe meeting included the ISH Emerging Leader
Awards. With these awards, the ISH aims to provide a platform to promote the research of
new investigators from each of the six ISH regions and increase inclusivity and representation
of the ISH globally.
At the close of the meeling. At ISH2024. Bryan Williams, ISH President 2022-2024, and
Dagnovar Aristizabal. ISH2024 Chairman. signed the Qattag2na￿o01aration- a call to action
to improve adherence to antihypertensive medications globally. The declaration highlights the
establishment of a World Adherence Day, the first of which will take place on 27 March 2025.
ISH 2026 Scientific Meeting
Dubai was selected as Ihe destination for the ISH 2026 meeting in 2023. The co-host of this
meetingwill be the Emirates Cardiac Society- Planning continued for this event in 2024, and
the meeting was officially launched at the end otthe ISH Cartagena September meeting.
TAR

Section D
Achievements (incl performaiice
ISH 2028 Sclentlflc Meetlng
Atthg end of 2028. the ISH and European Socioty of Hypertenslon {ESHI leadershlp signed an
agreement to hold a joint meeting in 2028 in Europe, in the tradltlon of several successfulloint
meetings in the p8St. with proposals to hostthe meeting Invlted In 2025.
In 2024, th8 ISH contlnued to p8rtn8rwith theJoum81 of Hypertension. 88 the official joumal of
the Soclety. In addltion to prlmary papers from world-renowned experts. the Journal
Ipublished bywolters Kluwerl contsins authorltatlve revlews that 8ummarlse and ev81uate the
most signlflcant recent developments. Further 88lf-published items include ISH Hypertansion
N8ws la magazlne produced approximately 3 times per yearl read bythe Socletys more than
7.000 Members and 8ubscribers and the ISHmonthtye-8ulletln.
Papers publlshed in 2024 by the ISH or with ISH le8dershlp authorshipwere as follows.
Inrtovatloni In blood pressure measurgment and reportlngtschnoiogy: Internalional
Soclety of Hypertension po3ltlon paper endors￿ bythe World Hypertenglon League,
European Soclety of Hyportanslon. Aslan Paclflc So¢lety of Hypertonglon, and Latln
Amerlcan Soclety of Hyperten81on
New blood pressure me8surement devices such as cuff-1988 wri8t monitors are likely to play
an important rol8 in hyp8rt8n8ion diagnosis 8nd management In future- but several
challenges remain before these newtechnologies can be introduced widely. accordingto 8
new position paper from the Internatlonal Soclety of Hypert8n8ion IISHI.
A key Challenge Is that these new devices 8re not yet 88 8ccurate or reliabl8 as existing blood
pressure monltors. The posltlon paper-wti￿￿ti£d in theJoum81 of Hypertension- looks at the
evidence arouncl the accuracy. validation and clinlcal utllity of new kinds of blood pressure
monltors and other innovations in hypertension.
Prioritles to redu¢¢ thè burden of hypertenslon In Afr1￿ through ACHIEVE
A paper published in the February 2024 issue of The Lancet Global He81th outlines the work ot
the Accelerating African Control of Hypertension through Innovative Epidemlology and a
Vibrant Ecosystem IACHIEVE) Inltlatlve. ISH President 2022-2024. Bryan Williams was one of
the authors.
The ISH Research and Education Committ88 commenced work In 2024 to develop multiple
new position papers for publlcatlon in 202S and 2026. Authorship of the papers will Include
r8pres8ntstion from Society leadership and membership in all regions whore possible,
including 8 high p8rcents88 of woman and new investigators as collaborators.
To add to this. the Societyworked with the Endocrlne Soclety on thelr new guideLin&s- to be
released In 2025.
The ISH. 88 8 respected body of expertise, is frequendy asked to endorse events and
publications. It assesses these requests on the basis of criteri8 which are published on its
website.The ISH Research. Sclence and Education Commlttee and Counciitypic8IIy
consider sev8r81 such requests each month. A sample of the successful requests follows.
Cllnlc81 Hyperten8lon Fellowship from the World Kldney Ac8demy. The f¢llow$hip 18 an
onllng programme 81ructured as 3 moduL8$- 14 week8 88ch- almed at m?diGal
doctors and h8alth¢are work•rs Involved In hypertension Gare, from anywhere In the
world.
Servier EVIDENTSummit- a 1-day event in the Middle E8St Re
ion focused on
TAR

Sectioii D
Achievements and perforinaiice
overcoming medication nonadherence and treatment inertia for patients with
cardlometabollc dlse8$es.
Th81 Hyp8rtenslon Camp org8nl8ed by the Thai Hypertenslon Soclety (THSI. Four
one-dayworkshops took place- wlth 20 participants 8tt8ndlng each tlme to equlp
8ttend6esto become champions In hypertensSon care Inthe hospltatswhefe they
w￿rk.
Abbott's a.care congress h8ld In October commltted to advanclngtreatment
adherence 8nd behgvioural science through research. evld8nc8-based practlces,
and ¢oUaboratlve d18CU88lon8.
To forge stronger Ilnk8 wlth natlon81 and r8glonal socletles of hyp8rt8nslon and r8L8t8d
bodles, create wlder awareness of the So¢lety and to ¢ontlnue to dissemlnate Intorm8tlon
regardlngthe 2020 ISH Glob81 Hypertgnslon Pr8Ctlce Guld611nes, the ISH work8- malnly vla
Its six R8glon81 Advl80ry Groups IRAGs)- wlth 8fllllgted socletles end sends Teachlng
Faculty, Councll mgmbgr8 or other members of th8 ISH188dershlp to p8rtlclp8tè in. and
offer educatlon81 content at, numerous global a¢ilvltle8 each year.
ISH representatlves presented at, and hold lolnt sesslons, at a great number of
educ8tlonal and teachlng actlvltles and meetlngs In 2024 laddltlonal to the ISH2024
Sclentifl¢ Me8tln8 In C8rtagena, Colomb181 Includlng:
AFRICA
August: Southem Afrl¢8n Hyp8rtenslon Soclety Blennl81 Congre88 In
Joh8nn88bur8.
AMERICAS
Aprll: Argentlno Soclety of HypertenBlon ISAHAI. ISH 8UPPOrted th8 new Investig8tor
gW8rd8 presented on th18 occa810n.
August: Brazlllan Soclety of Hypertenslon
APAC
F8bru8ry: Indono8lan Soclety of Hyperten$lon Iln6SHI
June: Vletnamese Socletyof Hypertenslon (VSHI
July.. M8L8yJl8n Soclety of Hypertenslon IMSHI
October: Japanese Soclety of Hypert8n8lon IJSHI
November: Korean Soclety of Hypertenslon IKSHI
December: Chlnese Hypertenslon League ICHLI
December: Hypertenslon Austr8118
EUROPE
Aprfl: ISH Presldent 2022-2024 Bryan WIILlams 8nd Past Pre81dent M8cieJ
Tom8SZ8wskl wer8 part of g 8rltlsh Heart Foundatlon18HF) weblnar explorlng rlsk8
assoclated wlth high blood pressure and how It can be man8ged.
June.. European Society of Hypertenslon IESHI Meetlng ijolnt ISH-ESH Sesslon
August: European So¢lety of C8rdlology IESCI l Jolnt ISH-ESC S8881on
MENA
March: ISH MENA Reglonal Advlsory Group Hypertenslon Symposlum
June: ISH MENA Regional Athil80ry Group Hypertenslon Symposlum
August: Iraqi Society of Hypertenslon
December: ISH MENA Regional Advlsory Group Hypertenslon Symposlum
SACA
September: Paklstan Hypertenslon L88gu8 M8etlng
TAR

Section D
Achievernents Ilnd perlormc?nce
The ISH was pleased to support the18unch of a n8w report at the EU P8rll8ment on 30
January to Improve adherence to hyperten81on treatment. The event was attended by
ISH Past Pr88ident M8clel Tomaszewskl IUKI and ISH Councll member Claudio Borghl
Iltaly).
ISH contlnued to endorse the Certlflcat8 Hyperten81on Programme in Spanlsh
organlsed by the Argentlne Soclety of Hypertenslon ISAHAI 8nd wlth signlllc8nt
support given from the ISH Ameflc8s RAG. Thls comprehenslve program cons18ted ol
16 modules. fg8turlng both synchronous and asynchronous classes.11 Is designed for
physl¢lan$ In the L8tln Amerlcan region aspiringto bacome hyportension experts. 90
Pgoplg 8radu8tgd from the 2-year C8rt1fic8t8 Course In 2024 from the second edltlon
of th8 course.
Work commenced by the ISH Atrlca RAG In 2024to creete a slmpllfled, unllled Afrlcan
guideilne derlv8d from the ISH 2020 guldellnes and other locally avallable evidence,
wbth the 81m of publlshlngthls In 2025.
The Soclety addttlonally worked wlth th8 followlng global organlsatlons and hypertenslon
related socletlgs to Bupport the followlng actlvltlé8:
STRIDE BP e-learnlng plattomi: STRIDE 8P18 an Intern8tlonal 8clentlflc non-proflt
org8nlzatlon that provldes guld8nce on the mathodology 8nd technologyfor accurate
blood pressure evaluatlon. It18 offlclally supported byth8 ISH, tho European Soclety
oIHypert8nslon, and the Wortd Hypertension League. tstsp&ll￿
Glob81 Coailtlon for Clrculatory H081th IGCCHI: GCCH brlngs together 32
Intarn8tlonal, reglon81 and natlonal 8takeholder8 In clrculatory health to drfve the
urggllt g¢tlon ngaded to comb8t h98rt dl3e888 and 8trok8. Th8ir effort8 Includ
publl8hlng posltlon paper8 and whlte papers.
OMRON Ac8d8my: ISH contlnuéd to 8UPPOrt Omron Healthcare wlth thelr onllne
currlculum on hyperten81on. OMRON Academy18 a currlculum framework made ty
expert sclentlsts and offers contSnuous medlc81 educatlon for healthcare
professlon818. The tralnlng highllght8 speclllc ch8118ng88 In the fleld of hypertenslon
nd respiratory dlse8se and offers update8 on tha18te8t Édv8nc88 In th8s8 fi81d8. The
onllne course8 8re d8v8lopèd for moblle and desktop use and the hypertgn8lon
courses are endorsed bythe ISH, European Soclèty ol Hypert8nslon IESHI and the
Britlsh 8nd Irlsh Hyperten3lon Soclety IBIHSI. After completlng each module,
P8rt1clp8nts recelve 8 certlllcate of complètlon whlch c8n b8 used lor contlnulng
medlc816ducatlon ICMEI credlts.
LOo￿ngforWard to 2025:
PL8n8 were advanced In 2024 to launch an ISH speclallsed educatlonal platlorm called ISH
Ac8demy.
The Academy ISH educatlonal pl8lfonn Is In thè proc￿3 of belng establlshed to provlde
standardised. high-qu81ity content for ISH members. Thls wlll off8r a go to place for the
hypertension community end educ8tlon81 pLattoim will discuss various aspects of
hypertension. The aim is for accreditation to be offered so those completing the process wlll
be recognised by their peers. Thè course wlll offer a curriculum and notjust a series ol
presentstlons and be upd8ted on an ongoing basls to keep thls current.
TAR
10

Section D
Achievements and performance
IENS.IDMBES.Eatio
IEiiir.EEacIiyJTJES:
New investigator Cornrnittee INICI
The Society continued to encourage interaction and involvement with the ISH Nèw
Invesligator Network on the Society website and via social media plattorms, F8¢ebook X
and Linkedln. The Society circulated regular news via the main Society news channels to
focus on the 8chievements of new researchers or clinical scientists undertaking a higher
degree. To add to this, the spotlight section was retained on the Society webpages to
feature hypertension future leaders.
Mentorship and TrainingCommitte8 IMTCI
The focus ol the Mentorship and Training Committèe in 2024 was to continue the
successful ISH Mentorship Scheme. This is an exciting scheme designed to bring together
new investigators (students and hypertension researchers who are within 10 years of 8
doctoral degree) and more experienced investigators.
Womgn in Hypertension Research Committee ￿1HRCI
The long-term goal of the Women in Hypertension Research Committee IWIHRCI is to address
the barriers to progression that aff ect women and other under-represented groups within the
society and to ensure equality of opportunity for all across the Society's activities and within
the wider hypertension research community. With their activities the WIHRC are aiming to
promote their mission. This is..
To promote women scientists and clinicians so that they can fulfil their career
aspirations in hypertension and related CVD.
To provide a plattorm for networking and mentoring
To recognise and promote successes ofwomen in the hypertension community
To encourage research in the field of 'hypertension and cardiovascular disease in
wornen
The spotlight section was retained on the Society webpages to provide an international
platform to promote outstanding women working in hypertension research, learn about their
scientific interestslachievements and to tell their person81 story.
Capacity BuildingNetwork
The ISH Capa¢ity Building Network IC8NI was lavnched on 27 November 2023 as a
collaboration between the 3 ¢ommittees (ISH NIC, MTC and WIHRCI to off er career
development and networking opportunities for early and mid-career researchers and those
from under-represented backgrounds. The collaboration will strengthen the activities of each
ol the committees and reduce duplication of effort. The 3 committees jointly organised
activities in 2024- primarily at the ISH2024 Cartagena rneetinE- to help equip investigators
with the skills they need to progress in research. See page 6. Whilst the focus of the CBN is on
researchers in the earlier stages ol their careers, all members of the ISH are welcome to
attend events.
Extensive efforts were made in 2024 to increase the level and content of communication from
the ISH to Society members and those non-ISH members engaged within the hypertension
community. ISH magazine- Hypertension News- continued to be sent to stakeholders and
made available on the open webpages. It is focused on scientific content and major updates
and remains highly readable. Our members regularly express interest in communicating and
exchanging their ideas via this publication. There were three issues in 2024. In addition, the
monthly e-Bulletin for membership was expanded to match the increased activity within the
Society and increased recognition of partner activity- Our magazine and bulletin are highly
valued, with open rates for our email bulletins around 40-500/0.
TAR

Sectlofl D
Acliievemttnt5 and performance
The Communicationsteam extensivelypromoted the ISH 2024 Cartagena. Colombia meetlng
via a mixture of traditional le•mail, Hypertenslon New8. E-bulletinl and social media trwitter.
Facebook. YouTube. Linkedln). All efforts were made and coordinated with the local
organlslng committee.
Other key activities in 2024 included supportlng the release of ISH posltlon p8pers, promotlng
the ISH Colombia 2024 Sclentific Meeling 8nd ISH 2026 Dubai Meeting, as w811 a8 extensive
Pfomotlon ofthe membership restructure and newfree memb8r8hip ¢8tegory op8n to anyone
interested In high blood pressure.
In 2024the ISH upgraded Its website to provide easier navigation and a higher quality browsing
experignce for our members and vi8itors.
The ISH Is also keeplng upto-date on modern communic8tion pr8¢tlces. ampioying us8 of
video, and new social media platforms. For éxamplè, the Society is now on Instagram and
Blues￿. This extends the reach and visibility of our cherltable activities.
We also use our¢omms platfoms a5 a way of promotingthe work and activities of our
8ffili8ted national and regional societies around the world.
Addltlonal new and ongolng p8rtnershlps V￿re establlshed and malntalned wlth the
following organisations- 8P8rt from the ongoing relationship thatthe Society has with over
80 natlonal hypertenslon and cardiac socletles globally.
European Society of Hypertenslon IESHI. Asian Pacific Society of Hypertension IAPSHI.
L8tln-American Society of Hypertenslon. Endocrine Society, Resolve to Save Lives, KDIGO
BP measurements standardization ¢onsen8US Partnership* C8rdiov8scu18rRes88rch.
World Health Org8niz8tlon IWHOI. Framework Convention Alliance for Tobacco Control.
Internatlon81 Alliance of Patients, Organizations. Intematlonal Council of Nurses.
Intgrnational DiBbetes Federation, Intern8tlonalSoci8ty of N8phrolobry. Wortd Federatlon
of Public Health Associations. World Heart Federation, Wortd Hypertension Le8gue (WHLI,
World Organization of Family Doctors. World Stroke Organiz8tion. and Int8rnation81
Atherosclerosis Societyvia the Global Co81ition for Circulatory Health IGCCH) and
HEARTS Initiative led bythe WHO.
The ISH estsbli8h8d a flagship global progr8rnme through 8 new Pstient Guideline
Inltiatlve, made possible by an Industry grant. This patient-focused guideline will provide
people worldwide with the ess8ntialtools and knowledge requlred to effectlvely detect,
monitor. and control their blood pr8ssure.
The ISH changed its legal ststus to a Chafltsble Incorporatsd Org8ni8ation ICIOI and on 29
September 2023. the new CIO was entered on the Register of Charities wlth the registered
Charity number 1204969. Assets were transferred from the Unincorporated Charity to the CIO
on 2310 December 2024 and the Unlncorpor8ted Charity was closed, The CIO h8$ a new
Constitution. and the aims and objectives are based on those of the Unincorporated Charity.
TAR
12

Section E
Financial review
Brief statement of
the charity's policy
on reserves
The financial position of the Society is Gonsidered by the Trustees to be in good order As
shown by the financial statements.
As the Society does not undertake fundraising from the general public and in view of the
uncertainty of long-term support from the Biennial Scientific Heelings and Corporate
Members, the Trustees h8ve approved a strategy to maintain the balance of the accounts to
reasonable sum of at least-£500,000 to guarantee sustainable charitable activities in the
event of unfavourable financial circumstances.
The Society also wishes to contlnue Its policy of holding Biennial Scientific Meetings in
regions of the world which on occasion, may not attract as much sponsorship as others and
It is therefore important to maintain sufflclent reserves as indicated above to 8nsure existing
commitments are met in the event that the 8iennial Scientific Meetings do not make a
signiflcant surplus. This was notably the case for the Colombla 2024 Sclentlfie Meeting which
was the first ISH meeting held in Latin Amerlca since 2004 and an Invaluable opportunity to
better connect with the community in the region and expand the reach of the Society.
Flnanclal Overvlgw lor 2024
Total Income for the year amounted to £318,008, representing an Increase ot £97,582
Compared lo 20231£220,4261. This increase is mainly attributable to a grant received
01 £1 OOK (equivalent to E86,684- ISH Empowerment 231241, which has been treated
as restricted fund income.
Direct ¢h8ritable expenditure in 2024 totalled £334,904, which Includes foreign
exchange losses of É15,958. Charitable expenditure in 2023 totalled £304,798
Expendlture exceedgd income by £7 6,896, resulting in a net reduction in funds for the
Society.
This resulted In a tot81 lunds balance of £911,054 as of 31 December 2024,
compared to £927,950 in 2023
New charitable expendltures have been commltted lor 2025, Includlng further educational
activltles in the region5.
It Is also th8 aim ol the Society to further build 115 research activities, and it is therefore
import8nt to have suff ici8nt reserv85 to honour these longer-term research commitments.
Further flnan¢ial rovlew detalls Iopllonal Inlormatlonl
You may choose to
include additional
intormalion, where
relevant about:
The charity's
principal sources
of funds
(including any
fundraising).
How expenditure
has supported
thekey
objectives ol the
charity.
Investment
policy and
The Soclety's programme of 8du¢8tional activities is funded primarily in four ways..
1. Royalties.. The Society receives 8 sm811 percentage of the revenue made by theJourn81 or
Hypertension, the Society's official journal.
2. Corporate Members- The contributions made by approximately 5 commercl81 companies
enable the Society to continue to develop existing initiatives and provide new educational
resources and activities. Donations from our in(Justrial partners are received on the condition
that all activities undertaken by Ihe Society are managed by the Trustees alone, 8nd that the
Corporate Member5 are not involved with any decision-making.
3. Project and endorsement support.. Industry contributes project and endorsement support
either to acknowledge ISH'S endorsement or to facilitate specific Society initiatives.
4. Biennial Scientific Meetings.. The Society receives a percentage of any surplus from these
conferences. This amount can vary considerably each time, depending on how rnuch income
TAR

objectives
including any
ethic81
investment policy
adopted.
is received from sponsorship and registration fees.
5. Membership subscription fees.
Our overarching investment objective is to achieve a combination of sustainable growth and
income. We aim to generate returns that allow us to fulfil our charilable purposes while
carefully preserving the capital value of our portfolio. To manage liquidity and earn a return
on short-terrn funds, a portion of our cash balances will be held on interest-be2ring deposit.
RESPONSIBILITIES OFTHE TRUSTEES FOR THE FINANCIALSTATEMENTS
The Trustees are responsible for preparing the report of the Trustees. and the financial
statements in accordance with applicable law and regulations.
The Trustee5 must not approve the financial statements unless they are satisfied that they
give a true and fair view of the state of affairs of the charity of Ihe incoming resources and
application of resources, including the income and expenditure, of the charity for that period.
In preparing these financial statements. the Trustees are required to-
select suitable accounting policie5 and then applythem consistently;
observe the methods and principles in the Charities SORP;
make judgments and estimates that are re8son8ble and prudent.
state whether applicable UK accounting standards have been followed, subject to
any material departures disclosed and explained in the financial statements- and
prepare the financial statements on the going concern basis unless it is inappropriate
to presume that the charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to
show and explain the charity's transactions. disclose with reasonable accuracy at any time
the linancial position of Ihe charity and enable them to ensure that the financial statements
comply with the provisions of the charity's Constitution. They are also responsible for
saleguarding the assets of the charity and hence lor taking ieasonable steps lor the
prevention and detection of fraud and other ifregu18rities.
Section F
Other optional information
Not applicable
Section G
Declaration
Th8 trustees declare that they have approved the trustees, report above.
Signed on behalf of the charity's tru5tee5
Signaturelsl
Full namelsl
Position leg secretaryp chair)
Professor George Stergiou
President
Date
27th October 2025
TAR
14

IrfftRNATIONAL SOCfEfY OF HYPERTENSION
REPORT OF THE TRusfEES- soaEfY INFORMATION
FOR THE YEAR ENDED 310ECEMBER 2024
trLE5tee5 p￿ent thelr report wth the fir￿ndal ststements of the dwrity fty the yeor ended 31 December 2024. The
tru*es have adopted the provlslons of Attounttng and Repjtlng by Charlves.. Statement of Recommended Prath
appllcable to tha￿￿e$ prepartng thelr ￿Unts In accordan￿ wth the Anandal Reportong Standanl applicable in the UK
ènd Republk of Ireland (FRS 102) (effecuve l January 2019).
srRucfuRE. GOVERNANCE AND MANAGEMETtr
Governlng document
The charity Is govemed by its ulnsuts￿0n, Is a C￿rItable InC￿￿￿3￿j OrganisatbJn (ao).
REFERENCE AND ADMINlSfRATIVE DEfAILS
Registered Chartty number
1204969
Prlnclpal address
clo Advènts Chartered Accountsnts
29 Gildredge Road
BN214RU
Professor M Tomaszew5ki {res￿ned 21.9.24)
Professor F Charchar (reS￿ned 21.9.24)
Professor D Prabhakardn (reslgned 21.9.24)
Profe550r C Borghi (resfgned 21.9.24)
Professor N Khan Ireslgned 21.9.24)
Dr H Itoh
Dr G Sterglou
Professor M tho
Professor U M SteckellNJs
Professor B Imlllams
Profe550r T Jafar
Ass Prfw C A Romero
ProfessiK K K Kariti
Professor E S W Jones {aprdnted 21.9,24)
Professor H Behelry (apwlrted 21.9.24)
Profe550r D Colombarf lapkM)Inted 21.9.24)
Profe55tsr J AristlzabakOcampD (arvjlnted 21.9.24)
Professor Y ti {apFolnted 21.9.24)
IndepeDdont Examlner
Mr T Durrant
Advanta
artered Accountsnts
29 Glldredge Road
E& Sussex
BN214RU
The detsiled trustees ryKJrt Is set out on pages TAR I to 14.
Page I

INDEPENDENT EXAMINER'S REPORTTO THE TRUSTEES OF
INTERNATIONAL SOCIETY OF HYPERTENSION
Independent examlner's report to the trustees of Internatlonal Society of Hypertension
I report to the charity trustees on my examination of the accounts of Interriational Society of Hypertenslon (the CIO) for
the year ended 31 December 2024.
This report is made solely to the trustees a5 a body, in accordance with the Charities Act 2011. My
examination has been undertaken so that I mlght state to the trustees those matters l am required to state
to them In an independent exarniner's report and for no other purpose. To the fullest extent perTllitted by law, I do not
accept or assume responsibility to anyone other than the charity and the trustee5 a5 3 bodyi for my exarnination,
for this report, or for the opinion5 1 have formed.
Responslbilitles and basls of report
As the charity trustees of the CIO you are responsible for the p￿paratIon of the accounts in accordance with the
requirernents of the Charities Act 20111'the ACVI.
I report in ￿$pert of my examination of the CIO'S accounts carried out under SeLtion 145 of the ALt and in carrying out
my examination I have followed all applicable Directions given by the Charity Commission under Settion 14515llb) of the
Art.
Independent examlnerfs statement
sin￿ your charity's gross income exceeded £250,000 your examiner rnust be a member of a listed body. I can confirm
that l am qualified to undertake the examlnation because l am a member of the A550Ciation of Chartered Certified
Accountants, which is one of the listed bodies.
I have completed my examlnatlon. I conflrm th81 no material matters have come to my attentlon In connection with the
examlnation glving me cause to believe that In any material respert..
ccounting records were not kept in respett of the CIO as requlred by Sectlon 130 of the Act,. or
the accounts do not accord with those records., or
the accounts do not cornply with the applicable requirements con￿MIng the form and content of accounts set
oul in the Charities (Accounts and Reports) Regulation5 2008 other than any reqU1￿ment that the accounts glve
a true and fair view whlch is not a matter considered as part of an independent examination.
I have no concerns and have corne across no other rnatte￿ in connection wlth the examlnation to whlch attention
should be drawn in this report in order to enable a proper Unde￿tandIng of the accounts to be reached,
Mr T Durrant
Advants
Chartered Accountants
29 Glldredge Roèd
Eastbourne
East Sussex
BN214RU
Date.. 27 ¢)rtober 2025
Page 2

INTERNATIONAL SOCIETY OF HYPERTENSION
srATEMENT OF FINANCIAL AcnvrriES
FOR The YEAR ENDED 31 DECEMBER 2024
2024
Totsl
funds
2023
Totsl
fvnds
Unrestricted Restrttted
fvnd
fund
INCOME AND ENDOWMENYS FROM
Donatlons and legacies
1,162
1,162
8,065
atltsble ath￿e$
Invesbment Incorne
225,318
86,684
312,iX12
210,888
Total
231325
220 426
EXPENDrnIRE ON
Charitsble actlvltles
CharftsNe acbvrbe5
307 817
Totsl
307 817
NEf INCOMEI{EXPENDrnIRE)
(76,492)
59,597
(16,895)
(84,372)
RECONCILIATION OF FUNDS
Totsl fvnd5 brought forward
927,950
927,950
1,012,322
TOTAL FUNDS CARRIED FORWARD
851458
911055
C014TINUING OPERATIONS
All knctwne al￿ eyndSture has artsen frcwn continulng adNths.
AJI comparatfve figures relate to tr£ old charlty.
The fomi part ofthe5e finandal statements
Page 3

31 DECEMBER2024
2023
Total
furKIs
fund
fund
fur¥Js
Thnglble assets
li
198
2,198
12
134,864
756 033
134,864
130,220
Cash at
890W7
59,597
1,084,443
CREDrroRS
unts lalllro wRhln ¢)ne y¢Jr
13
(41,637)
(41,637)
{IS6,493)
908
851,458
911A155
927,950
NrfASSErs
851458
FUNDS
Unrnstrtth funds
Restrkted funds
14
851,458
927,950
TOTAL FUNDS
st•l8 nts appTh&J by Ihe Bojrd d TTUSfte$ Ind thrthorw for on
o%f.. and Igr•d on ks behaw ty:
C A Rornero-Tri

INTERNATIONAL SOCIEfY OF HYPERTENSION
NOTES TO THE FINANCIAL sfATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
ACCOUNTXNG POUaES
Basls of preparlng the flnandal statements
The financkl 51atsments of the dKrlty, whlch Is a publlc benefft enuty under FRS 102, have been prepared In
ICCOTdano with the Charltles SORP {FRS 102) 'Aco)unting and Repo￿n9 by CharfUes', Statement of
Recommended Prac0￿ ap￿kOble to charlttes preparlng thelr accoLsnts In accordance wth the Flnandal
Repo￿n9 Stsndard applkable In the UK and Republlc of Ireland (FRS 102) (effethve l January 2019),, Ananclal
Reporting Standard 102 The Flnandal Rewilng Stsndard applicable In the UK and Republlc of Ireland, and the
Charltles Att 2011. Tr finandal ststements have been prepared under the hlstorh21 cost conventson.
The finandal statsments are prepa￿d In Sterllngi Is the funcyonal currerKy of the ch*.
All the assets, Ilabllths, and aCb￿ of the intemavonal Sjdety of Ftypertenslon (UnIrK￿￿Orated cha￿ty
reglstrntlon number 1122135) transferred from that to the ao unlntenupted a5 at 23 December 2024.
The flnandal statements have prepared u51ng meryer accaundng. ￿1 comparatlve flgures relate to
the old chartty.
Golng concern
At the tlme of apffing the finandal statsments, the Trustees have a reaFA)able expectsuon that the
Intematlonal Wety of Hypertenslon has adequate resources to con￿n￿ In operdtlonal exISten￿ for the
I0￿seeable f(rtu￿. Thus the Trustees condnue to adopt the golng concem bals of acoJunUng In weparlThJ the
financlal statements.
ZncDm•
All Income 1$ recognlsed In tr* Ststement of Flnandal AthI￿e5 orKe ￿ chartty hos enutlement to the funds,
Is probable that the Snc(rfne wlll be recelved arKI the omunt can be mea￿red rellably.
Cash donayons are recogntsed on recelpt. other donauons Jre recognlsed On￿ the Internawonal Sojety of
Hypertenslon has teen nO￿tled of the donauon, unless perfornian￿ condlttons ￿￿lre defernl of the sum.
Interest on funds held on depostt ts IrKluded when re￿(Vable and the amount can be MeaSu￿d rellth by the
charlty. th1515 nomally nouficatton of the Interest patd or payable by the b)nk.
Expndltur•
Uabtifdes are recc¥nlsed as expendlture as soon as there ts a legal or construLthe obllgatlon ComM￿n9 the
thartty to that expendltuye, It Is prnboble that a transfer of economlc benefits wlll be requlred In settlement and
the amount of the obllgatlon can be measured rellably. eXpendItu￿ Is accounted for on an accruals basls and has
been dasslfled under headlngs that aggregate all cost related to the category. Where costs cannot te dlrecty
attrtbuted to pa￿CUlar headlngs they have been allcated to athvlttes ¢Jn a basls consLstert wth the u* of
Grants offertd subjert to Condl￿onS whth have not l)een met at the year er#1 date are noted as o commltsn￿t
Ixrt not accrued as expendlture.
Twnglble flxed ••8ots
Depredatton Is provtded at the followlng annual rntes In ryder to wrfte off each asset over Its estlmated usefvl
Fl>Xures and ffttlrrfJs
Computer equlpment
33% on cost
33% on cost
Taxatlon
The charity Is exempt from CWFOra￿on tsx on ts tharftswe acuwues.
Fund accountlng
Unrestrlcte(I funds on be used In accordan￿ the charltsble obSethes at the dlscretlon of the trustees.
Restrlcted fijnds can onty be used parucular restrtcted purposes wfthin tr* objects of the charlty.
Rethclors arf5e vthen 5￿fied by the donor or when funds are rdlseA for parttcular restrlcted purposes.
Further explanatton of tre [wtU￿ and purpose of each fund15 Snduded In the notes to the llnandal ststements.
Page 5
C0n￿nUed...

IIITeRNAT1014AL SOCIEfY OF HYPERTENSION
IIOTES TO THE FINANCIAL STATEMENTS- eontlnu¢d
FOR THE YEAR ENDED 31 DECEMBER 2024
ACCOUNTING POUCIES. conllnued
Forelgn currenci•#
A55ets and liabil￿eS In forelgn currencies are translated Intt> stsrflng at the rates of exchange rullng at the
balan￿ sheet date. Transacttons In fOre￿n currendes are translated Into *rling at ts Rte of exchange rullng
at the dats of transacvon. Exchange dIfferen￿ are tsken Into accourt In arTlvlng at ts ¢werd￿n9 result.
Penslon c4Mts other pogt-retlmment benefits
The tharfty operate5 a defined cothbuuon penslorb xheme. ContrlLKth>ns payable to the chartys penslon
stheme are charyed to the Ststern￿t of Rnandal AcVvMes In the pertod to whlth they relats.
Flnandal 1MtNm￿tl
The Internadonal Sodety of Hypertensl¢xs On￿ enters lrto baslc flnandal Instrument transad¢￿S that result In
the recognthn of Anandal assets and l￿bI1rde$ Ilke trnde and other detrtors and ¢yedltors.
Debt Ir￿me1￿ that a￿ poyable or ￿￿1va￿e wlthln one year, typkally trade debtors and credltors, are
measured, Inldally and sUbseqUen￿y, at the undlscounted amount of the cash or other con4deraYon, expetted to
be pald or recelved.
FSnanthl assets that are measured at cost and amortlsed cost are assessed * the end of each repNOng perfod
for obJe¢Uve eVIden￿ of ImpalmienL If objedve evidence of Impalment ts found, an Impalmient loss Is
recognlsed In wofft and loss.
For Ilnandal assets measured at c05L the Impalrment loss Is measured as the loss betrmn an asset
carrytng value Jnd the present value of fu￿re cashflow dlscounted atthe assevs odglnal effethve lrterest rnte.
Flnandal Ilabl1￿leS are derwntsed wl*n the thdty's contractual obllgatlons explre or are dlscharged or
cancelled.
CRfncAL ACCOUNTING JUDGEMENTS AND KEY SOURces OF EsfiMATION UNCERTAINTY
In applICa￿an of the Intsmayonal Sodety of Hypertenslon's aCcoun￿ng pollctes, the Trustees a￿ requlred to
make judgements, esymates and assUMp￿¢)nS of the carrylng amount of assets and Ilabllths that are not readlty
apparent from other Sour￿5. the esilmates and a5sc(lated assumpUons a￿ based on hlstorfcal exF¢deft￿ and
other faLtors censtdered to be relevant. ktual results may dlffer from these esdmate5.
The ertlmatss ar￿ underfwng assumpY¢Jts are revlewed on an ongolng basls. Revlslons to accoUn￿n9 estlmates
re recognlsed In the perfoj In whlch the esUmate15 revLfed where the revlslon affects onty that Fedod, or In the
perk￿ of r￿SlOn arml firture pedod where the revlsEon effects ¢w￿nt and fvIu￿ pertojs.
CHARrrABLe ACTIVMES
2024
2023
CorForate rnemtrorshlp fees
Membetshlp fees
Blennlal meetlng
Joumal of Hypertenslon Royalde5
Pauent guldellne 1n6t1a￿ve
ISH branded endotsements
61,817
15,852
19,936
104,8
67,423
13,310
1342)
106,671
31
Page 6
contlnued...

INTeRNATfoNAL SOaEfY OF HYPERTENSION
NOTES TO THE FINANCIAL sfATEMEIITS- (Mllhyed
FOR THE YEAR ENDEO 31 DECEMBER 2024
INVEsfMENT INCOME
2024
2023
Depos￿ account Interest
Grnnt
fundlng of
acUvlVes
Support
costs (see
note 6)
Dlrect
Totsls
Charttabie actlvltles
156 482
Inltlthe and meeyng expertses are shown In fvll to provlde the fullest posslble InfomHUon. Durlng ts year
IrKome of £19,936 {2023: £(3421) was re￿Ived from dor￿r5 and 5pon50f5 tt> (kfray those costs.
SUPPORT cosrs
Govemance
Managemert
Totsls
Ch8rttble aCtIv￿eS
arthble athltles. depredthi
146,086
9,296
155,382
Governance cots Incl￿les payments to the fimi that employs the Independent examlner of £5,000 (2023:
£5,080) for Independent examlnayon fees and for the prepbrnkn of the annual flnandal statements to ctynply
wlth the Charlttes Acts, aThl £1,711 (2023: £554) for other serv1￿.
TRusfEIS' REMUNERATION AND BeNeFrrs
None of the Trustees (or any persons connrfted vAth them) recew any remunernUon or benefits from the
Interna￿ana[ Sodety of Hypertens1￿ durlrwj the year,
EMPLOYEES
The￿ w45 one (2023: one) employee durEng the yw.
Page 7
c￿ttIn￿￿...

IIITERNAnONAL SOCZEfY OF HYPERTENSION
NOTES TO THE FINANCIAL sfATEMENTS- (¥ntlnyed
FOR THE YEAR ENDED 31 DECEMBER 2024
EXCEPTIONAL rrEMS
Ex￿p￿onal thms Include fO￿Ign exchange I¢￿ In the sum of £15.958 (2023.. £411901. These Include unreallsed
galns and losses arfslng as a result of revaluln9 fcrel9n exchange balan￿ uslrvj the rate prevalllng at the end of
the finandal year.
COMPARATIVES FOR THE STATEMEKf OF FINANCIAL AcfIvrnES
Tctsl
funds
fvnd
fund
INCOME AND ENDOWME14TS FROM
Ch)nattons and legaaes
0￿ritab￿ aCtiV￿e$
Investment Income
8,065
210,888
8,065
210,888
Total
EXPENDITURE ON
th)rftable atti¥itieg
Charitsb￿ acti￿ties
126 086
Totsl
NEf ZNCOMEIIEXPENDrnIRE)
(84,3ni
(84,372)
RECONCILIATION OF FUNDS
Totsl funds brought fornard
1,012,322
1,012,322
TOTAL FUNDS CARRIED FORWARD
927 950
11. TANGIBLE FIXED ASSErs
F￿re$
and
eqLdpment
Ccrfnplrter
equlpment
Totals
Additions
DEPRECIATION
arye for year
267
NET BOOK VALiIE
At 31 December 2024
532
At 31 Decanber 2023
Page B
ontinutyj...

NOTES TO THE FINANCIAL sfATEMeNTS. CQDthiued
FOR THE YEAR ENDED 31 DECEMBER 2024
12. DEBTORS. AMOUIITS FALUNG DUE WITHIN OIIE YEAR
2024
2023
5,910
21,229
39
105,143
Other detrtors
lal 5ecurbty & (tt*r taxes
21,229
106,671
13. CREDrroRS: AMOUIITS FALUNG DUE WITIIIN ONE YEAR
2024
2023
Trade uedknrs
Sodal seojrlty and other taxs
21,640
26,206
4,210
10,787
2,229
122,429
I& MOVEMElff IN FUNDS
1.1.24
fvnds
31.12.24
Unv••irfct•d fvnd•
Genwjl fuKI
927,950
(76,492)
851,458
Re•trktsd fundi
Pat*nt G￿delIne In
59,597
59,YJ7
TOTAL FUNDS
Net movémert In fijnds, In tts abtht aR as frknth"
In funds
Generdl fund
231,324
(3)7￿16)
(76,492)
(27,088)
59,597
TOTAL FUNDS
318
crfflunued...

INTERNATIONAL SOCIEfY OF HYPERTENSION
NOTES TO THE FXNANCIAL sfATEMErir5- contlnued
FOR THE YEAR ENDED 31 DECEMBER 2024
I& MOVEMENT IN FUNDS- contlnued
Comparatlves for movement In lund•
Net
rnovem￿t
In funds
At 1.1.23
31.12.23
Unrertrfctad funds
Genernl fund
1,012,322
(84,3n)
927,950
TOTAL AINDS
1012 322
COmpara￿Ve net mOveM￿t In funds, Induded In the al￿ are Js fdlows:
Incomlng
Resources
expended
Movement
In funds
Unrq•trlrted fund•
General fund
220,426
{304,798)
(84,3n)
TOTAL FUNDS
A current year 12 monts and prtor year 12 months comblned pothon15 as folk>ws:
Net
movement
In funds
At 1.1.23
31.12.24
Unr••trlct•d fund¥
General fund
1,012,322
(160,864)
851,458
R••trlct•d fund•
Pavent Guldellne Inthtlve
59,597
59,597
TOTAL FUNDS
1012 322
101267)
911055
A current year 12 months and prlor year 12 months com￿ned net movemert In fvnds, Induded In the above a
as follows:
InLvmlThJ
Resour￿5 Movement
In fijnds
Unrestrlctad fund#
General fvnd
451,750
(612,614)
(160,864)
R￿trItt￿ funds
Pauent Guldeline Inidthe
86,685
(27,088)
59,597
TOTAL RINDS
639 702)
101267
Pdge 10
conun￿1...

INTERNATIONAL SOCIETY OF HYPERTENSION
NOTES TO THE FINANCIAL sfATEMENTS- contlntrtd
FOR THE YEAR ENDED 31 DECEMBER 2024
MOVEMENT IN FUNDS- tt•ntinued
Purpose of restrkw fund
The Patient Guldellne Initiative Fund was stsrted ty a grant of £86,684 gfvi to the tharfty to create a new
fiagshlp gbbal wogramme ￿SH Ernpowert. Thts 15 a pthnt ￿ntred guklellne to emF&v￿r W*nts to bthr
detec¢ mon¢tor and control thelr blood pressu￿.
The resttItt￿ fund wa5 trdnsferred to the CIO and any rethcUon5 In tKeserved.
I& RELATED PARTYTRANSAcfioNS
No key management personnel rece￿ any remuneratk>n In tr￿ thrrent or p￿or year.
During the year the Intemational SOC￿ of Hypertension entered Intrj the follothng trar￿￿On$ wlth S(￿ of Its
trustees, in respect of travel an(J accomrnc#Jalion expenses relmtyjrsed In the sum of £101,662 (2023: £94.644}.
The number 0ftr￿ so reimbursed was 11 (2023: 12).
Page 11